You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:滬指跌破3000點!減肥藥、水利板塊逆市大升

A股主要指數今日進一步下跌,滬指跌破3000點。截至收盤,滬指跌0.24%報2998點,深證成指跌0.04%,創業板指跌0.39%。近2700股下跌,全市場成交6196億元較昨日縮量1048億元。

盤面上,昨日大升的教育板塊回落,科德教育跌超6%;EDR概念走低,鴻泉物聯跌超18%;Chiplet概念走弱,艾森股份跌超13%;能源金屬、光刻機及AI芯片等板塊跌幅居前。另外,工程諮詢服務板塊走高,新城市20cm升停;丹麥減肥藥廠Zealand新藥實現16周減重8.6%,減肥藥板塊活躍,金凱生科升停;水利部修訂發佈《水利技術標準體系表》,地下管網、水泥建材等板塊走高,華藍集團升停;民爆概念、生物製品及珠寶首飾等板塊升幅居前。

具體來看:

教育股跌幅居前,創業黑馬跌超7%,科德教育跌超6%,凱文教育、中國高科、全通教育、豆神教育等跟跌。

光刻機概念走低,富樂德、波長光電、華亞智能跌超5%,藍英裝備、新萊應材、張江高科等跟跌。

腦機接口升幅居前,創新醫療、力合科創升停,翔宇醫療升超8%,誠益通、三博腦科、愛朋醫療、南京熊貓等跟升。

消息面上,美國卡內基梅隆大學研究團隊成功地整合了一種新型的聚焦超聲刺激技術,在一項涉及 25 名受試者的研究中,實現了雙向腦機接口功能,並利用機器學習對腦電波進行編碼和解碼。

水利股大升,舜禹股份、新城市、華藍集團20cm升停,設研院、龍元建設、西藏天路、美麗生態等多股10cm升停。

消息面上,近日水利部修訂發佈《水利技術標準體系表》,充分發揮水利技術標準的導向性、引領性、推動性、基礎性作用,為全面提升國家水安全保障能力提供技術支撐。

減肥藥概念表現活躍,金凱生科20cm升停,甘李藥業升超7%,聖諾生物升超6%,博瑞醫藥、諾泰生物等跟升。

近期,減肥藥行業的領軍企業如禮來和諾和諾德市值屢創新高,邁向萬億市值俱樂部。丹麥明星減肥藥廠Zealand週四發佈成績單,新藥實現16周減重8.6%。另有市場研究預測,至2028年全球減肥藥市場規模有望達到284億美元。

個股異動

貴州茅台收跌1.94%,報1471元,創2022年11月以來新低。貴州茅台年內累跌超13%。有數據顯示,貴州茅台是近期外資連續拋售期內成交量最大的股票,當前外資持股比例已經降至6.75%,為今年1月以來最低。據酒價參考數據,茅台1935批發參考價今日跌破800元/瓶大關,報780元/瓶,已經出現價格“倒掛”的情況。

展望後市,摩根士丹利稱,預計A股短期內將維持區間震盪,建議投資者保持謹慎,聚焦個股策略和主題投資。其表示,儘管中國A股市場情緒略有回升,但4至5月份宏觀數據好壞不一,再次證明宏觀面的壓力依然存在,通縮風險依然揮之不去。

大摩指出,中國決策層下半年或將加快實施已宣佈的財政支持措施,包括5000億元科技創新和技術改造再貸款,以及3000億元保障性住房再貸款等。建議投資者密切關注後續政策,這對於維持市場情緒至關重要,若後續政策行動若未能奏效,可能令投資者感到失望。建議聚焦個股策略,以及國企改革受益概念、高質紅利股以及“出海”等題材。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account